drugset / Trial / NCT01487083
A Long-Term Safety Study of Pomaglumetad Methionil in Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term safety of pomaglumetad methionil in participants with schizophrenia.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-10
- Completion
- 2012-10
Outcome
Outcome not reported
Stopped: “The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2140023 | Unknown | 20 mg | Oral |
| Subject | LY2140023 | Unknown | 40 mg | Oral |
| Subject | LY2140023 | Unknown | 80 mg | Oral |